Global Anti Infective Drugs Market Growth, Size, Research Report and Forecast 2024-2032

Anti Infective Drugs Market Size And Forecast

Anti Infective Drugs Market size was valued at USD 138.77 Billion in 2024 and is projected to reach USD 205.81 Billion by 2031, growing at a CAGR of 5.05% from 2024 to 2031

An important element fueling the market’s expansion is the rise in the prevalence of influenza. A contagious virus, influenza can result in both mild to moderate symptoms and serious complications, including death. The Global Anti Infective Drugs Market report provides a holistic evaluation of the market. The report comprises various segments as well as an analysis of the trends and factors that are playing a substantial role in the market.

Global Anti Infective Drugs Market Definition

One of the major global health burdens recognised by the World Health Organisation (WHO) is infectious illnesses. It is a potentially lethal illness brought on by a number of pathogens, such as bacterial, fungal, and viral infections. Anti-infectives are a form of therapy commonly used to treat infections brought on by a number of causes. Anti-infective drugs are used to eliminate infection-causing organisms or stop them from replicating or infecting the host by releasing a variety of toxins.

Microorganisms that cause infections include bacteria, viruses, fungi, viruses, and microparasites. Infections are categorised according to the type of organism that causes them as well as the patient’s signs and symptoms of illness. One of the most significant health issues facing the entire globe today is infectious diseases. It is a potentially lethal illness brought on by a number of pathogens, including bacterial, fungal, and viral infections. Infectious diseases spread swiftly, and anti-infective drugs are used to treat a wide variety of microbiological species, including fungi, bacteria, viruses, and other pathogens.

Anti-infectives are a form of therapy commonly used to treat infections brought on by a number of causes. Anti-infective drugs function in several ways, such as by blocking DNA production and/or by destroying the cellular component to stop the infection from spreading. The Anti Infective Drugs Market is populated by entities (organisations, sole traders, and partnerships) that produce branded or generic anti-infective pharmaceuticals to treat microbial illnesses as well as related products and services.

Global Anti Infective Drugs Market Overview

Humans are increasingly becoming susceptible to infections as a result of the human immunodeficiency virus (HIV), which damages the immune system. If HIV is not treated in a timely manner, Acquired Immunodeficiency Syndrome (AIDS) may manifest. Around 1.5 million people worldwide contracted HIV in 2020 alone, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV causes harm to or kills CD4 cells, often known as white blood cells. This interferes with the body’s ability to fight disease. Antiviral medications prevent the virus from multiplying, lowering the body’s level of HIV and reactivating the immune system’s cell production. Another important element fueling the market’s expansion is the rise in the prevalence of influenza. A contagious virus, influenza can result in both mild to moderate symptoms and serious complications, including death.

The expansion of the anti-infective drugs industry was boosted by the 35.5 million people who contracted influenza in 2018–2019, the Centres for Disease Control and Prevention (CDC) reports, which led to 490,600 hospitalisations and 34,200 fatalities. The Anti Infective Drugs Market is expected to benefit from recent advances in drug discovery methods, such as bone marrow and organ-on-chip (OOC) technology. OOCs are biometric systems that have been meticulously built to replicate the motions, movements, and physiological responses of organ systems. Target identification, validation, and screening are examples of clinical trial procedures that use OOC and stem cell technologies. These technologies are reducing the expenses associated with drug development and provide reliable predictions of medicinal efficacy and human safety.

Market expansion, however, can be constrained by high research and development costs as well as a lack of resources in healthcare facilities. However, The World Health Organisation (WHO) predicts that by 2030, one in every six people will be 60 years of age or older and that by 2050, the number of people in the world who are 60 years of age or older will have doubled (to 2.1 billion). The number of people 80 and older is expected to treble between 2020 and 2050, reaching 426 million. Age-related immune system deterioration renders the body’s capacity to fight disease and respond to immunisations less effective. The immune system becomes less adept at telling self-agents apart from alien ones. T cells that retain memories of previously met antigens react less quickly to novel antigens. Due to an increase in comorbid disorders and a decline in immune system activity, people are more susceptible to infections, which is what is causing the market to grow.

Global Anti Infective Drugs Market Segmentation Analysis

The Global Anti Infective Drugs Market is segmented on the basis of Drug Type, Indication, Distribution Channel, And Geography.

Anti Infective Drugs Market, By Drug Type

• Antibiotics
• Antivirals
• Antifungals

Based on Drug Type, the market is segmented into Antibiotics, Antivirals, and Antifungals. Anti-infective medications known as antibiotics are used to treat bacterial infections. They function by either eradicating the germs or preventing them from proliferating, allowing the body’s immune system to successfully combat the infection. A variety of bacterial illnesses, including those of the respiratory system, skin, urinary tract, and ears, are frequently treated with antibiotics. They come in a variety of forms, including tablets, capsules, injections, creams, and ointments.

A class of anti-infective medication known as antiviral is used to treat viral infections. They function by concentrating on the virus and halting its reproduction and spread throughout the body. Virus diseases like the flu, herpes, HIV/AIDS, hepatitis B and C, and other viral infections are frequently treated with antivirals. Depending on the infection type being treated, they can be given orally, topically, or intravenously.

Anti Infective Drugs Market, By Indication

• HIV
• Pneumonia
• Respiratory Infections
• Tuberculosis
• Others

Based on Indication, the market is segmented into HIV, Pneumonia, Respiratory Infections, Tuberculosis, and Others. Pneumonia is an infection of the lungs that can be brought on by bacteria, viruses, fungi, or other pathogens. Anti-infective medications are used to treat pneumonia. Depending on the underlying cause of the infection, the anti-infective medication used to treat pneumonia is chosen. The initial line of therapy for bacterial pneumonia is antibiotics. They function by eliminating infection-causing germs and lowering lung inflammation. Penicillin, cephalosporins, macrolides, fluoroquinolones, and tetracyclines are a few of the typical antibiotics used to treat bacterial pneumonia.

Antibiotics are frequently used as the first line of treatment for bacterial respiratory infections like streptococcal pharyngitis (strep throat), bacterial sinusitis, and bacterial pneumonia. The particular antibiotic administered will depend on the kind of bacteria that is infected and how susceptible it is to various medications. Penicillin, cephalosporins, macrolides, fluoroquinolones, and tetracyclines are typical antibiotics used to treat bacterial respiratory infections.

Anti Infective Drugs Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Others

Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Others. Anti-infective medication is primarily distributed via hospital pharmacies. These pharmacies are in charge of obtaining, holding, dispensing, and controlling the stock of medications used to treat infections in the hospital context. Given the high prevalence of infectious disorders among hospitalised patients, anti-infective treatments are among the most often prescribed ones in hospitals.

To ensure proper selection, dose, and administration of anti-infective medications, hospital pharmacies often collaborate closely with doctors, including infectious disease specialists and other healthcare professionals. In addition, they are in charge of keeping an eye on and handling any potential negative drug effects, interactions, and problems with drug resistance.

Anti Infective Drugs Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of The World

On the basis of Geography, the Global Anti Infective Drugs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The biggest market share was held by North America in 2022. In recent years, a number of reasons have contributed to an increase in the need for anti-infective medications in North America. The rising incidence of infectious diseases, notably bacterial and viral infections, in the area is one of the major contributors to this trend.

The need for anti-infective medications has also been influenced by the ageing population and the rise in chronic illnesses including diabetes, cancer, and HIV/AIDS. The expanding prevalence of infections that are resistant to treatment is another factor influencing the increased demand for anti-infective medications in North America. To treat these infections, new and improved antibiotics and antiviral medications are now required.

Key Players

The “Global Anti Infective Drugs Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Novartis AG, Merck & Co., Inc., Alcon Pharmaceuticals Ltd., Quest Diagnostics Inc., AstraZeneca Plc., Anofi SA, GSK, Gilead Sciences, Novartis AG, and Cipla.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In August 2021, Pharmaceutical business Xellia Pharmaceuticals, which specialises in anti-infective medications, increased its Ohio production capacity. They distributed the first anti-infectives produced at the facility to US hospitals.
• In April 2021, Pfizer, a large global pharmaceutical and biotechnology company, acquired Amplyx Pharmaceuticals, Inc., a business that creates treatments for crippling and fatal illnesses and added Fosmanogepix, a novel antifungal Phase 2 candidate (APX001), to its anti-infectives portfolio. Pfizer now owns Amplyx’s early-stage therapeutic portfolio, which includes antiviral (MAU868) and antifungal (APX2039) medications.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Anti Infective Drugs Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behaviour of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Anti Infective Drugs Market, gauge the attractiveness of a certain sector, and assess investment possibilities.